GlassScriptPhysician profile
Brian C Adair
NPI 1720057995
$2,583.15
in general payments reported to CMS, 2019-2025
25 companies · $1,193 in 2025
The $1,193 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $12.43 · 2021: $163 · 2022: $162 · 2023: $212 · 2024: $597 · 2025: $1,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925 · Entertainment: $77.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,924.55 |
| Entertainment | $77.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $916.45 | 2019-2025 | Clareon, Ngenuity, Luxor |
| Bausch & Lomb Americas INC. | $290.86 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $254.85 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $137.65 | 2019-2025 | Tecnis Iol, Veritas Vision System |
| Kala Pharmaceuticals, INC. | $113.53 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $105.95 | 2019-2021 | |
| Dutch Ophthalmic, USA | $101.89 | 2023-2024 | Tissueblue, Eva, Combined Machine |
| Abbvie INC. | $92.24 | 2023-2025 | Durysta |
| Beaver-Visitec International, INC. | $77.51 | 2024 | |
| Harrow Eye, LLC | $61.06 | 2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $57.13 | 2019-2021 | |
| Amgen INC. | $54.29 | 2024 | Tepezza |
| Lensar, INC. | $51.59 | 2025 | Lensar Laser System |
| Sight Sciences, INC. | $39.79 | 2022 | |
| Rxsight INC | $36.66 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $28.43 | 2023-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $24.88 | 2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $22.19 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $18.88 | 2023 | Veracity Surgical |
| Rayner Intraocular Lenses Limited | $18.69 | 2023 | Rayone Spheric, Omidria, Rayone Emv |
| Novartis Pharmaceuticals Corporation | $17.15 | 2022 | |
| Tearlab Corp | $16.32 | 2021 | |
| Ocular Therapeutix, INC. | $16.29 | 2024 | Dextenza |
| Allergan, INC. | $16.00 | 2019 | |
| Glaxosmithkline, LLC. | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Adair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.